Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TTR | P02766 | 2/20 | 0.34 |
| ▸ | PTPRC | P08575 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | DAO | P14920 | 2/20 | 0.32 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27723749 | 0.82 | TSHR (0.41) | TSHRTP53ALOX15ALDH1A1DAO | |
| SCHEMBL14829070 | 0.72 | — | — | |
| SCHEMBL8565178 | 0.67 | MAOA (0.35) | TSHRTP53ALOX15NFKB1BLM | |
| SCHEMBL19750859 | 0.67 | TSHR (0.35) | TSHRTP53ALOX15ALDH1A1DAO | |
| SCHEMBL10964095 | 0.67 | ALOX15 (0.36) | TSHRTP53ALOX15NFKB1BLM | |
| SCHEMBL10955588 | 0.65 | — | — | |
| SCHEMBL819903 | 0.63 | CCR2 (0.35) | TSHRTP53ALOX15BLMSMN1; SMN2 | |
| SCHEMBL22362544 | 0.60 | TSHR (0.35) | TSHRTP53ALOX15NFKB1BLM | |
| SCHEMBL813575 | 0.60 | TSHR (0.35) | TSHRTP53ALOX15ALDH1A1DAO | |
| SCHEMBL813574 | 0.60 | TSHR (0.35) | TSHRTP53ALOX15ALDH1A1DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4469182-A1 | SYSTEM AND METHOD FOR DIRECT AIR CAPTURE OF WATER AND CO2 | Battelle Memorial Institute (US) | 2024-12-04 | — | — | EP | disclosed |
| US-20230264138-A1 | SYSTEM AND METHOD FOR DIRECT AIR CAPTURE OF WATER AND CO2 | BATTELLE MEMORIAL INSTITUTE | 2023-08-24 | — | — | US | disclosed |
| WO-2023146800-A1 | SYSTEM AND METHOD FOR DIRECT AIR CAPTURE OF WATER AND CO2 | BATTELLE MEMORIAL INSTITUTE (US) | 2023-08-03 | — | — | WO | disclosed |
| US-20230233989-A1 | SYSTEM AND METHOD FOR DIRECT AIR CAPTURE OF WATER AND CO2 | BATTELLE MEMORIAL INSTITUTE (US) | 2023-07-27 | — | — | US | disclosed |
| US-10266737-B2 | Adsorption systems using metal-organic frameworks | ARKEMA INC. (US) | 2019-04-23 | — | — | US | disclosed |
| US-20150291870-A1 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | ARKEMA INC. | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291870-A1 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | PFAS, CHIA, PARN | TSHR 4470/4885TP53 1667/4885TTR 2175/4885 |
| US-10266737-B2 | Adsorption systems using metal-organic frameworks | PFAS, CHIA, PARN | TSHR 4470/4885TP53 1667/4885TTR 2175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.